South Korea’s drug safety agency said Friday it has approved pharmaceutical giant Celltrion Inc.’s COVID-19 treatment candidate on several conditions.…
Trending
- SAA trains farmers on improved maize production
- Delta allocates 99.99 hectares for Olam Agri plant
- ECOWAS moves to harmonise nursing training standards
- NCC: Device checker won’t access private data
- Tinubu approves ₦1trn pension intervention as FG clears 17-year backlog
- NHIA chief urges Nigeria to develop local health solutions
- Only 59% of Nigerian financial institutions ready for CBN data rule
- Sickle cell care in Africa must go beyond survival, experts say
